SMP-33693
SMP-33693 is a Drug-Linker Conjugate for ADC with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer[1].
Product Specifications
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/smp-33693.html
Solubility
10 mM in DMSO
Smiles
O=C(NC[C@@H](O)C[C@H]1O[C@@H](C[C@H]2O[C@@H](CC[C@H]3C(C[C@H](CC[C@]45C[C@](O6)([H])[C@@H]7O4)O3)=C)C[C@@H](C)C2=C)[C@H](CC(C[C@H]8CC[C@@]9([H])[C@]([C@H](O5)C6C7O9)([H])O8)=O)[C@H]1OC)CNC([C@H](CC%10=CC=CC=C%10)NC(CNC(CNC(CN%11CCOCCOCCN(C(CCCCCN%12C(C=CC%12=O)=O)=O)CCOCCOCC%11)=O)=O)=O)=O
Molecular Formula
C79H114N8O23
Molecular Weight
1543.79
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2970259-01 50 µg
Canine IgA kappa Isotype Control Monoclonal Antibody
Sign In for Pricing
View Details orb2970259-02 100 µg
Canine IgA kappa Isotype Control Monoclonal Antibody
Sign In for Pricing
View Details